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Abstract
In mammals, 5-HTexcitatory respiratory effects imply 5-HT1A receptor-mediated 
disinhibition of pre-Bötzinger complex neurons. In the lamprey, 5-HT1A receptors 
are involved in the neural control of locomotion, but their role in the respiratory 
regulation, particularly at the level of the putative respiratory rhythm generator, the 
paratrigeminal respiratory group (pTRG), is not known. We here investigate the res-
piratory function of inhibitory 5-HT1A receptors within the pTRG of the isolated 
brainstem of the adult lamprey. The 5-HT1A receptor agonists either bath applied 
or microinjected into the pTRG did not cause significant effects. However, the se-
lective 5-HT1A receptor antagonist (S)-WAY 100135 bath applied or microinjected 
into the pTRG induced depressing respiratory effects or even apnoea, thus revealing 
that 5-HT exerts a 5-HT1A receptor-mediated potent tonic influence on respiration 
and contributes to maintain baseline levels of respiratory activity. Microinjections of 
strychnine or bicuculline, either alone or in combination, into the pTRG prevented 
(S)-WAY 100135-induced apnoea. In addition, immunohistochemical studies cor-
roborate the present findings suggesting that 5-HT1A receptors are widely expressed 
in close apposition to the soma of glycine-immunoreactive cells located within the 
pTRG region. The results show that in the lamprey respiratory network, 5-HT exerts 
a tonic influence on respiration by a potent inhibitory control on both GABAergic 
and glycinergic mechanisms. The observed disinhibitory effects resemble the ex-
citatory respiratory modulation exerted by 5-HT1A receptor-mediated inhibition of 
glycinergic and/or GABAergic neurons present in mammals, supporting the notion 
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1 |  INTRODUCTION
Serotonin (5-HT) with its ionotropic and metabotropic re-
ceptors contributes to regulate many brain functions, includ-
ing breathing (for review see Hilaire et al., 2010; Hodges & 
Richerson,  2008, 2010; Jacobs & Azmitia,  1992). To date, 
at least 14 different 5-HT receptor (5-HTR) subtypes have 
been identified in mammals, which are grouped into seven 
families (5-HT1-5-HT7; Kroeze, Kristiansen, & Roth, 2002; 
Nichols & Nichols,  2008). These 5-HTRs are G pro-
tein-coupled receptors except the ligand-gated ion channel 
5-HT3R. The inhibitory 5-HT1AR is a major determinant of 
serotoninergic cell activity and of 5-HT release because of 
both its presynaptic and postsynaptic location (Chalmers & 
Watson, 1991). The 5-HT1AR is estimated to have differenti-
ated around 650 million years ago from the 5-HT1R subfam-
ily around the time during which vertebrates diverged from 
invertebrates (Peroutka & Howell, 1994). Most of the inver-
tebrate 5-HTRs resemble either the mammalian 5-HT1ARs or 
the 5-HT7Rs (Kroeze et al., 2002), thus suggesting that the 
5-HT1A or 5-HT7 subclasses represent the ancestral archetyp-
ical 5-HTRs.
Varied effects of 5-HT on the respiratory motor out-
put have been described in mammals mainly related to the 
complexity of the mode of action of this neurotransmitter. 
However, the bulk of evidence seems to support the conclu-
sion that 5-HT neurons play an excitatory neuromodulation 
of respiratory activity in mammals (Depuy, Kanbar, Coates, 
Stornetta, & Guyenet, 2011; Hilaire et al., 2010; Hodges & 
Richerson, 2008, 2010; Iovino et al., 2019; Ptak et al., 2009). 
5-HT-induced excitatory effects on respiration obviously 
depend on the combined activation of presynaptic and post-
synaptic 5-HTRs within the neural structures involved in the 
respiratory control (e.g. Dutschmann et  al.,  2009; Hilaire 
et  al.,  2010; Hodges & Richerson,  2008, 2010; Nichols & 
Nichols,  2008). According to previous observations in 
rodents (Corcoran et  al.,  2014; Manzke et  al.,  2009), re-
cently we have provided evidence in adult rabbits (Iovino 
et al., 2019) that 5-HT-induced excitatory respiratory effects 
are exerted mainly through a 5-HT1AR-mediated inhibition of 
inhibitory neurons at the level of the pre-Bötzinger complex 
(pre-BötC), the neuronal aggregate widely accepted to be re-
sponsible for the inspiratory rhythm generation (Del Negro, 
Funk, & Feldman, 2018; Feldman, Del Negro, & Gray, 2013; 
Janczewski, Tashima, Hsu, Cui, & Feldman,  2013; Smith, 
Ellenberger, Ballanyi, Richter, & Feldman,  1991). In more 
detail, a 5-HT1AR-mediated inhibition of glycinergic neurons 
has been found in rodents and cats (Corcoran et  al.,  2014; 
Manzke et al., 2009) and of GABAergic neurons in rabbits 
(Iovino et al., 2019).
The lamprey, a lower vertebrate which diverged from the 
main vertebrate line around 560 million years ago (Kumar 
& Hedges, 1998), has proved to be highly useful to identify 
the neuronal circuits underlying rhythmic motor behaviours, 
such as locomotion (e.g. Grillner, 2006; Grillner et al., 1995; 
Grillner & El Manira, 2019) and respiration (e.g. Bongianni, 
Mutolo, Cinelli, & Pantaleo,  2016; Cinelli et  al.,  2013). 
The isolated brainstem of the adult lamprey spontaneously 
generates respiratory neuronal activity in vitro. The puta-
tive respiratory central pattern generator is located in the 
paratrigeminal respiratory group (pTRG), a region ros-
tral to the trigeminal motor nucleus (Mutolo, Bongianni, 
Einum, Dubuc, & Pantaleo,  2007; Mutolo, Bongianni, 
Cinelli, & Pantaleo,  2010; Mutolo, Cinelli, Bongianni, & 
Pantaleo,  2011; Cinelli, Iovino, & Mutolo,  2013; Cinelli, 
Mutolo, Contini, Pantaleo, & Bongianni,  2014; Cinelli 
et  al.,  2016; Cinelli et  al.,  2017; for review see Bongianni 
et  al.,  2016; Milsom,  2018). The pTRG shows many simi-
larities with the mammalian pre-BötC (see e.g. Bongianni 
et  al.,  2016; Cinelli et  al.,  2017; Del Negro et  al.,  2018; 
Feldman et  al.,  2013; Smith et  al.,  1991). In fact, the two 
rhythm generators are under an extensive neuromodulatory 
control (Doi & Ramirez, 2008; Ramirez, Dashevskiy, Marlin, 
& Baertsch, 2016) and display similar sensitivity to opioid, 
substance P (SP), acetylcholine and ATP (Cinelli et al., 2013, 
2017; Mutolo et al., 2007, 2010, 2011).
The general organization of the serotoninergic sys-
tem in the lamprey is relatively well described and appears 
to share similarities with that of other vertebrates (Abalo 
et al., 2007; Antri, Cyr, Auclair, & Dubuc, 2006; Cornide-
Petronio, Anadon, Barreiro-Iglesias, & Rodicio, 2013; Pierre 
et al., 1992). Furthermore, it has been reported that the 5-ht1a 
transcript (i.e. the expression of the 5-HT1AR gene) is distrib-
uted throughout the entire central nervous system (Cornide-
Petronio et al., 2013). Interestingly, the expression of 5-ht1a 
transcript was also found within a region that corresponds 
to the pTRG. 5-HT is importantly involved in neural circuits 
controlling locomotion (Grillner et al., 1995) by slowing the 
frequency of fictive locomotor activity (Harris-Warrick & 
Cohen, 1985; Matsushima & Grillner, 1992; Buchanan, 2001; 
that some features of the neuronal network subserving respiratory rhythm generation 
are highly conserved throughout phylogeny.
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for review see Grillner, 2006; Grillner & El Manira, 2019). 
In this control, mainly postsynaptic 5-HT1ARs appear to be 
involved (e.g. Hill, Svensson, Dewael, & Grillner,  2003; 
Wang, Grillner, & Wallen, 2014; Wikstrom, Hill, Hellgren, & 
Grillner, 1995; Zhang & Grillner, 2000). A presynaptic role of 
5-HT1DRs has also been reported (Schwartz, Gerachshenko, 
& Alford,  2005). The role of 5-HT and 5-HTR subtypes, 
especially 5-HT1ARs, in modulating the respiratory rhythm 
generating network of the lamprey is unknown.
Comparative studies may offer a deeper understanding of 
neuronal rhythmogenic circuits and their evolution. Thus, the 
goals of this study were to investigate serotoninergic signal-
ling in the lamprey respiratory network, in particular to explore 
whether the5-HT1AR-mediated excitation of mammalian re-
spiratory network that occurs via disinhibition of glycinergic 
and/or GABAergic neurons (Corcoran et  al.,  2014; Iovino 
et al., 2019; Manzke et al., 2009), also occurs in the lamprey. 
To this end, we examined the effects on the respiratory activ-
ity generated by adult lamprey brainstems in vitro induced by 
bath application and microinjections into the pTRG of selective 
5-HT1AR agonists and of a selective 5-HT1AR antagonist. The 
effects of the local application of GABAA and/or glycinergic 
receptor antagonists were also studied. Immunohistochemical 
studies were performed to corroborate the results obtained with 
the glycine receptor antagonist strychnine.
2 |  MATERIALS AND METHODS
2.1 | Ethical approval
Experiments were carried out on 44 young adult (12–15 cm) 
sea lampreys (Petromyzon marinus) of either sex. Animals 
were captured in small rivers in Maine and Massachusetts 
and delivered by ACME Lamprey Company (Harrison, ME, 
USA). Lampreys (fasted) were kept in an aerated freshwater 
aquarium at 5°C, with a 12-hr light–12-hr dark cycle. Animal 
care and experimental procedures were conducted in accord-
ance with Italian legislation and the official regulations of 
the European Community Council on the use of laboratory 
animals (DecretoLegislativo 4/3/2014 no. 26 and Directive 
2010/63/UE). The study was approved by the Animal Care 
and Use Committee of the University of Florence. All efforts 
were made to minimize both the number of animals used and 
their suffering.
2.2 | Animal preparation
Animal preparation and experimental procedures were 
similar to those described in previous reports (Bongianni, 
Deliagina, & Grillner,  1999; Cinelli et  al.,  2013, 2014, 
2016, 2017; Mutolo et al., 2007, 2010, 2011). The animals 
were deeply anaesthetized with tricaine methanesulphonate 
(100 mg/L; MS 222, Sigma-Aldrich, St. Louis, MO, USA). 
To obtain the isolated brainstem preparations, the lamprey 
was immediately transected below the gills. Therefore, 
the anaesthesia was terminal. Muscles and connective 
tissues were removed, and the isolated brain–spinal cord 
was mounted dorsal side up in a Sylgard-lined recording 
chamber continuously perfused with a cold solution using a 
peristaltic pump. The chamber volume was 3.0 ml, and the 
perfusion rate was set at 2.5 ml/min. The dead space was 
7.5 ml. Thus, a drug added to the reservoir took ~3 min to 
reach the chamber. This time was considered in the evalua-
tion of the beginning of drug effects. Bath temperature was 
maintained at 9–10°C. The bath solution had the following 
composition (in mM): 91 NaCl, 2.1 KCl, 2.6, CaCl2, 1.8 
MgCl2,4 glucose and 23 NaHCO3. The solution was con-
tinuously bubbled with 95% O2-5% CO2 to oxygenate and 
maintain the pH in the bath at 7.4 at 9–10°C throughout the 
experiment. Under these experimental conditions, used in 
all previous studies on the isolated brainstem–spinal cord 
of the lamprey, the respiratory frequency is similar to that 
of spontaneous respiration of intact lampreys in the aquar-
ium at 9–10°C (Rovainen, 1977, 1996; Martel et al., 2007; 
see also Cinelli et  al.,  2014 for further references). The 
brain rostral to the optic tectum was cut and removed. A 
transection was made caudal to the obex (cervical region) 
maintaining a minimum length of spinal cord for holding 
the preparation. The roof of the isthmic region was cut 
along the midline, and the alar plates were spread laterally 
and pinned down.
2.3 | Recording procedures
Efferent respiratory activity was recorded bilaterally from 
the vagal nerves by means of suction electrodes. The signals 
were amplified, full-wave rectified and integrated (low-pass 
filter, time constant 10 ms). Extracellular neuronal activity 
was recorded with fine (0.1  mm shaft diameter) tungsten 
microelectrodes (5 MΩ impedance at 1 kHz). Neuronal ac-
tivity was recorded from respiration-related neurons of the 
pTRG, 1.8–2.0 mm rostral to the obex, 0.8–1.0 mm lateral to 
the midline and 0.25–0.3 mm below the dorsal surface (see 
e.g. Cinelli et  al.,  2017; Cinelli et  al.,  2013, 2014; Mutolo 
et  al.,  2007, 2011). These recordings were performed only 
with the purpose of ascertaining the localization of the pTRG 
for the subsequent execution of drug microinjections (see 
below). The obex was used as a reference point to evaluate 
coordinates of recording and microinjection sites. All re-
corded signals were analysed by a personal computer sup-
plied with an analog-to-digital interface (50  kHz sampling 
rate; Digidata 1440, Molecular Devices, Sunnyvale, CA) 
and appropriate software (Axoscope, Molecular Devices). 
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Clampfit software (Molecular Devices) was used for offline 
analysis.
2.4 | Drug application and histology
Drugs were applied to the bath solution to reveal their res-
piratory effects. They were also microinjected into the pTRG 
to ascertain their effects at this level. The preparation was 
perfused with the control solution for at least 60 min before 
control recordings to improve stability of respiratory motor 
output. The following drugs were used: (R)-(+)-8-Hydroxy-
DPAT hydrobromide (8-OH-DPAT; full 5-HT1AR agonist, 
more active enantiomer; Cat. # 1080, Tocris Bioscience, 
Bristol, UK) either bath applied (10, 50 and 100 μM) or mi-
croinjected (1 mM); BP 554 maleate (selective 5-HT1AR ago-
nist; Cat. # 0556, Tocris Bioscience) microinjected (1 mM); 
(S)-WAY 100135 dihydrochloride (potent and selective 
5-HT1AR antagonist; Cat. # 1253, Tocris Bioscience) either 
bath applied (100  µM) or microinjected (10, 100  µM and 
1 mM); strychnine hydrochloride (glycine receptor antago-
nist; Cat. # S8753, Sigma-Aldrich) and bicuculline methiodide 
(GABAA receptor antagonist; Cat. # 14343, Sigma-Aldrich) 
microinjected both at 1 mM. Drugs were usually dissolved in 
distilled water, except for (S)-WAY 100135 and BP 554 that 
were dissolved in 100% dimethyl sulfoxide (DMSO; Cat. # 
D8418, Sigma-Aldrich) and diluted to volume with the per-
fusing solution. In the final solution for bath application ex-
periments, DMSO concentration was 0.1%, while in the final 
solution for microinjection experiments DMSO concentra-
tion was always ≤1%. The pH of drug solutions was ~7.4. 
Stock solutions were made up and stored as small aliquots 
in a freezer until use. Stock solutions were diluted in the 
perfusing solution to the final desired concentration imme-
diately prior to bath application or to microinjections. Unless 
otherwise stated, only one drug was tested in each prepara-
tion. Drug concentrations were selected in preliminary tri-
als. They were similar to those employed in previous studies 
(see e.g. Cinelli et al., 2014; Johnson, Wilkerson, Henderson, 
Wenninger, & Mitchell, 2001; Ostrowski, Ostrowski, Hasser, 
& Kline,  2014; Sardari, Rezayof, & Zarrindast,  2015). In 
these trials, as in a previous study (Mutolo et al., 2010), con-
trol experiments with equivalent amounts of DMSO in the 
perfusing solution were performed. They showed that the sol-
vent had no effect on respiratory activity. Drugs applied to the 
bath were allowed to perfuse the brainstem for ~20 min. After 
completion of each drug challenge, either with bath applica-
tion or with microinjections, the preparation was allowed to 
recover by perfusing it with the control solution for a maxi-
mum of 2 hr. Higher concentrations of neuroactive drugs are 
required with local application due to the exponential decay 
of drug concentration with the distance from the pipette tip 
as well as to other factors including the large dilution volume 
constituted by the extracellular space and the continuous 
washout in the recording chamber. Microinjection procedures 
have been extensively discussed in previous reports (Lipski, 
Bellingham, West, & Pilowsky,  1988; Nicholson,  1985; 
Nicholson & Sykova,  1998; see e.g. Bongianni, Mutolo, 
Carfi, & Pantaleo,  2002; Mutolo, Bongianni, Nardone, & 
Pantaleo, 2005).
Bilateral microinjections (0.5–1 nl) of different drugs into 
the pTRG were performed by means of glass micropipettes 
(tip diameter 10–20 μm) and by applying pressure pulses of 
50–100 ms with a Picospritzer (General Valve Corporation, 
Fairfield, NJ) connected to the injection pipette. The volume 
was estimated by measuring the diameter of a droplet ejected 
from the tip of the pipette with an ocular micrometre in a 
dissecting microscope. Bilateral microinjections were per-
formed using a single micropipette that was withdrawn after 
the first microinjection and then introduced contralaterally 
for the second injection. The interval between the two mi-
croinjections ranged from 20 to 30 s. The inactive dye Fast 
Green (0.2%, Sigma-Aldrich) was added to the drug solution 
to visually assess the spread and the approximate localization 
of the injectate within the pTRG by judging the position of 
the dye spot with respect to the sulcus limitans of His and the 
isthmic Müller cell I1 (Cinelli et al., 2017, 2013, 2014). The 
depth of the injection (~0.3  mm below the dorsal surface) 
was inferred from that of rhythmic extracellular neuronal ac-
tivity previously recorded in each preparation. Control micro-
injections of equal volumes of the vehicle solution with 0.2% 
Fast Green dye were also made prior to drug injections. On 
some occasions (n = 3) green fluorescent latex microspheres 
(LumaFluor, New City, NY) were added (dilution 1:3) to the 
drug solution (1 mM (S)-WAY 100135) for post hoc confir-
mation of injection sites (see also Cinelli et al., 2014). After 
each experiment, the brainstem was fixed (4% formalin in 
0.1 M phosphate buffer (PB), pH 7.4, overnight), cryopro-
tected with 30% sucrose, frozen and cut at 20 µm thickness 
on a cryostat. Coronal sections stained with cresyl violet were 
used for the histological control.
2.5 | Immunohistochemistry
Experiments were performed for immunohistochemical detec-
tion of glycinergic neurons and 5-HT1AR expression within 
the pTRG (n = 4). The dissection, fixation and sectioning of 
the lamprey brains were performed as previously described 
(Cinelli et al., 2017, 2013, 2014). The preparation was similar 
to that employed in the electrophysiological experiments de-
scribed above. The brains were dissected out of the surround-
ing tissue, fixed by immersion in 2% formalin/0.1 M PB pH 
7.4 for 12 hr and cryoprotected in 20% sucrose/PB for 3–12 hr. 
Transverse 20-µm-thick sections were made using a cryostat, 
collected on gelatin-coated slides and stored at −20°C until 
   | 5CINELLI Et aL.
further processing. Primary and secondary antibodies were 
diluted in 1% bovine serum albumin (BSA) and 0.3% Triton 
X-100 in 0.1 M PB. Sections were incubated for 24 hr at 4°C 
with a rat polyclonal anti-glycine antibody (1:5,000; Cat. # 
IG1002; Lot # 1131; ImmunoSolutions, Jesmond, New South 
Wales; RRID: AB_10013222) and a mouse monoclonal anti-
serotonin receptor 1Aantibody (clone 19A9.2; 1:500; Cat. # 
MAB11041; Lot # 2424802; Millipore Corporation, Billerica, 
MA; RRID: AB_10806903). After a thorough rinse in 0.01 M 
phosphate-buffered saline (PBS), sections were incubated with 
a mixture of Alexa Fluor 488 goat anti-mouse IgG (1:200; 
Cat. # A-11077; Invitrogen, Life Technologies, Carlsbad, CA; 
RRID: AB_141874) and Alexa Fluor 568 goat anti-rat IgG 
(1:200; Cat. # A-11029; Invitrogen; RRID: AB_138404) for 
2 hr at room temperature. Sections were then coverslipped with 
glycerol containing 2.5% diazabicyclooctane (Sigma-Aldrich). 
The specificity of glycine antibody used is known from pre-
vious studies in the lamprey (Cinelli et al., 2016; Mahmood, 
Restrepo, & El Manira, 2009) and is consistent with the find-
ing of glycine immunonegative areas, such as that correspond-
ing to the anterior rhombencephalic reticular nucleus (see 
Figure 5b). The mouse monoclonal antibody against 5-HT1ARs 
has been used in the mammalian central nervous system 
(Azizi et al., 2017; Iovino et al., 2019; Li et al., 2018; Millon 
et al., 2016). It has not been previously used in the lamprey. 
The specificity of the 5-HT1AR antibody can be hypothesized 
since 5-HT1ARs are highly conserved in the central nervous 
system throughout the vertebrate evolution (Cornide-Petronio 
et al., 2013) and, in addition, 5-HT1AR labelling with the em-
ployed antibody is virtually absent in some regions adjacent to 
the pTRG (see Figure 5b). However, we have not provided any 
evidence that this antibody is really specific also in the lamprey 
brain. Therefore, we have to admit that its cross-reactivity with 
other antigens is possible. For these reasons, we will refer to 
5-HT1AR-like immunoreactivity in the text. Furthermore, no 
immunoreactivity was detected when primary antibody was 
omitted from the immunohistochemical processing.
Whenever antibody expression levels were compared, 
tissues were processed simultaneously. Photomicrographs 
of key results were taken using a Nikon DS-Fi1 (Nikon, 
Japan) digital camera and software. Images were captured 
and processed in Adobe Photoshop CS6 (Adobe Systems 
Inc., San Jose, CA; RRID: SCR_014199) using identical set-
tings. Images were only adjusted for brightness and contrast. 
Illustrations were prepared in Adobe Photoshop CS6 and 
Adobe Illustrator CS6 (Adobe Systems Inc., San Jose, CA; 
RRID: SCR_010279).
2.6 | Data collection and analysis
Data collection and analysis were performed according to 
procedures already described in our previous reports (see 
e.g. Cinelli et  al.,  2017). We measured respiratory fre-
quency (cycles/min), vagal burst duration (ms, measured on 
raw activity) and peak amplitude of integrated vagal activity 
(taken as an index of the intensity of vagal bursts, arbitrary 
units) that were normalized by expressing it as a fraction (or 
percentage) of mean control value (relative unit, RU). All 
these variables were measured and averaged for 20 s in the 
period immediately preceding each trial (control values) as 
well as at 1-min intervals during the experimental challenge 
and after recovery. In two experiments where (S)-WAY 
100135 was bilaterally microinjected into the pTRG, long 
trace recordings were also performed. As a rule, average 
values of respiratory variables observed in control condi-
tions, at the time when the drug-induced responses occurred 
and in the recovery period were taken for statistical analy-
sis (Prism 7, GraphPad Software Inc., La Jolla, CA; RRID: 
SCR_002798). We considered respiratory activity fully re-
covered when the studied variables were within  ±  3% of 
their control values. One-way repeated-measures ANOVA 
followed by Bonferroni's multiple comparisons tests were 
used to assess the differences in the effects of a series of 
experimental conditions on the same group of animals. In 
particular, this analysis was used to investigate the time 
course of respiratory responses to bath application or mi-
croinjections of (S)-WAY 100135 and related recovery (5-
min intervals). Student's paired t tests were also employed 
when appropriate. Changes in respiratory variables were 
also expressed as percentage variations of control values. 
The number of preparations is indicated by n. An analysis 
of the prolonged vagal bursts, described as “coughs” (see 
Cinelli et al., 2017 also for further references), was consid-
ered beyond the scope of the present research. All values 
are presented as means ± SEM; p < .05 was considered as 
significant.
3 |  RESULTS
3.1 | Role of 5-HT1ARs within the lamprey 
respiratory network
Given the pivotal role of 5-HT1ARs in the modulation of 
a different rhythmic motor activity in the lamprey, that 
is locomotion, we focused on this receptor subtype. Bath 
application (n  =  3) of 100  µM 8-OH-DPAT, a selective 
5-HT1AR agonist, did not within 10 min cause any obvi-
ous or consistent effect on the respiratory frequency (from 
61.4  ±  2.1 to 60.8  ±  1.8 cycles/min; p  >  .05, Student's 
paired t test). Amplitude and duration of vagal bursts were 
also unaffected by 100 µM 8-OH-DPAT (p always > .05, 
Student's paired t tests). Lower concentrations of 8-OH-
DPAT (10 or 50 µM) were also without effect. Similarly, 
bilateral microinjections of 1  mM 8-OH-DPAT into the 
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pTRG (0.5–1 pmol; n = 4) did not produced any signifi-
cant effect on respiratory frequency (from 59.8 ± 1.6 to 
61.1  ±  1.5 cycles/min; p  >  .05, Student's paired t test). 
The other respiratory variables did not display signifi-
cant changes (p always > 0.05; Student's paired t tests). 
The lack of 8-OH-DPAT effects was somewhat surpris-
ing. However, this finding was corroborated by some 
experiments performed making use of another 5-HT1AR 
agonist. Bilateral microinjections into the pTRG of 1 mM 
BP 554 (0.5–1 pmol; n = 3) did not induce within 10 min 
any significant change in the respiratory frequency (from 
60.3  ±  2.0 to 60.7  ±  1.7 cycles/min; p  >  .05, Student's 
paired t test). Also, the amplitude and duration of vagal 
bursts were not affected (p always  >  0.05; Student's 
paired t tests). Thus, we examined possible tonic sero-
toninergic influences on respiration by bath application 
of the selective 5-HT1AR antagonist (S)-WAY 100135 
at 100 µM (n = 4). Unexpectedly, this drug induced ap-
noea (Figure 1a). The time course of respiratory responses 
and their recovery are illustrated (Figure 1b). Respiratory 
frequency was 60.5 ± 2.7 cycles/min under control con-
ditions and started to decrease within 2 min after bath ap-
plication of the antagonist. Apnoea ensued within 10 min. 
These latter effects were accompanied by progressive re-
ductions in the amplitude of vagal activity. Respiratory 
activity slowly, but completely recovered after 60–70 min 
washout.
The effects of S-WAY 100135 at the pTRG level, in-
vestigated by using microinjection techniques, proved to 
be dose-dependent. Bilateral microinjections of different 
doses of S-WAY 100135 were performed. While 10  µM 
S-WAY 100135 (5–10 fmol; n = 3) was ineffective, 100 µM 
(0.05–0.1 pmol; n = 4) caused depressing effects on the re-
spiratory activity and 1  mM (0.5–1  pmol; n  =  4) apnoea. 
These respiratory responses were analysed by a one-way 
repeated-measures ANOVA. The analysis of the effects in-
duced by 100  µM S-WAY 100135 provided the following 
results: F(8,24) = 20.33, p = .0064 for respiratory frequency, 
F(8,24)  =  33.83, p  =  .0001 for peak vagal amplitude and 
F(8,24) = 1.438, p = .3078 for the duration of vagal bursts. Post 
hoc analysis showed that S-WAY 100135 at 100 µM reduced 
within 5 min the respiratory frequency (from 58.5 ± 1.9 to 
36.5 ± 5cycles/min; −38.3 ± 6.9%; p = .0315) and the am-
plitude of vagal activity (−41 ± 3.5%; p =  .0062), without 
significant concomitant changes in the duration of vagal 
bursts. The decrease in respiration persisted for ~10  min. 
The recovery was achieved within 40 min (Figure 2a). The 
same statistical analysis of 1 mM (S)-WAY 100135 effects 
provided the following results: F(12,36) = 154.6, p < .0001 for 
respiratory frequency, F(12,36)  =  117.2, p  <  .0001 for peak 
vagal amplitude and F(12,36) = 292.6, p =  .0002 for the du-
ration of vagal bursts. The apnoea ensued within 5 min after 
the completion of the injections and persisted for ~15 min. 
Respiratory activity completely recovered within ~60  min 
(Figure 2b). The time course of respiratory responses induced 
by 100  µM and 1  mM S-WAY 100135 and their recovery 
are illustrated (Figure 2c). The localization of one (S)-WAY 
100135 injection site into the pTRG, ascertained with green 
fluorescent latex microspheres added to the injectate, is il-
lustrated in Figure 3. This finding is consistent with that re-
ported in our previous studies (Cinelli et al., 2014; Mutolo 
et al., 2007, 2011). In 3 preparations, control microinjections 
of equal volumes of the vehicle solution containing 0.2% Fast 
Green dye at the responsive sites (3 trials) as well as bilateral 
F I G U R E  1  Respiratory responses to the 5-HT1AR antagonist, 
(S)-WAY 100135. (a) Apnoeic response induced ∼10 min after 
bath application of 100 μM (S)-WAY 100135 in one preparation. A 
complete recovery was observed after ∼70 min washout. Traces are 
raw vagal nerve activity (VA) and integrated vagal nerve activity 
(IVA). (b) Time course of respiratory responses induced by bath 
application of 100 μM (S)-WAY 100135 (n = 4). The antagonist 
caused within a few min progressive reductions in both respiratory 
frequency and amplitude of vagal activity. Complete apnoea ensued 
within 10 min. Ctr, control. The onsets of bath application of (S)-
WAY 100135 and washout are indicated by arrows. Values are 
means ± SEM. *p < .05, **p < .01 compared with control
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microinjections of 1 mM S-WAY 100135 at sites >0.4 mm 
far from the responsive region (4 trials) did not induce any 
apparent respiratory response. These control microinjections 
were made into the trigeminal motor nucleus as well as at 
more rostral sites into the mesencephalic region (see also 
Cinelli et al., 2013).
F I G U R E  2  Respiratory effects of (S)-WAY 100135 microinjected into the pTRG. Long trace recordings of integrated vagal nerve 
activity (IVA) in one brainstem preparation under control conditions and at different times following bilateral microinjections of 100 μM 
and 1 mM (S)-WAY 100135 (arrowheads). (a) 100 μM (S)-WAY 100135 induced depressing effects on respiratory activity that reached 
a maximum at ∼5 min (arrow) and persisted for ∼10 min. Recovery ∼40 min after the injections. Expanded traces show control baseline 
respiratory activity, decrease in respiratory frequency and amplitude of vagal activity 10 min after the completion of the injections and 
recovery of respiratory activity. (b) 1 mM (S)-WAY 100135 caused depressing effects on respiratory activity within 1 min and apnoea 
∼3 min (arrow) after the completion of the microinjections. Apnoeic effects lasted for ∼15 min. Recovery ∼60 min after the injections. 
Expanded traces show control baseline respiratory activity, apnoea 10 min after the completion of the injections, and recovery of respiratory 
activity. Pauses in the ongoing respiratory activity indicate the presence of “coughs.” (c) Time courses of respiratory responses caused by 
microinjections of 100 µM and 1 mM (S)-WAY 100135. Ctr, control. (S)-WAY 100135 microinjections are indicated by arrows. Values are 
means ± SEM. *p < .05, **p < .01 compared with control
Control
1 mM (S)-WAY (pTRG)
3 min Recovery
IVA
100 μM (S)-WAY (pTRG)
IVA
IVA






























Ctr 0 10 20 30 40 50 60
Time (min)








































8 |   CINELLI Et aL.
3.2 | Inhibitory mechanisms involved in the 
mediation of respiratory responses caused by 
5-HT1AR blockade
Taking into account disinhibition phenomena induced 
by 5-HT1ARs in mammals (Corcoran et al., 2014; Iovino 
et al., 2019; Manzke et al., 2009), we hypothesized that 
the apnoeic responses could be mediated by disinhibition 
of glycinergic and/or GABAergic mechanisms acting 
on neurons located in the pTRG region. To address this 
issue, the respiratory responses induced by the 5-HT1AR 
antagonist were investigated during the blockade of gly-
cine and/or GABAA receptors. Interestingly, blockade of 
glycine receptors by bilateral microinjections of 1  mM 
strychnine (0.5–1 pmol; n = 4) into the pTRG prevented 
(S)-WAY 100135-induced apnoea. In the analysis of 
(S)-WAY 100135-induced effects during glycine recep-
tor blockade, a one-way repeated-measures ANOVA 
provided these results: F(3,9) = 26.78, p =  .0105 for res-
piratory frequency, F(3,9)  =  3.205, p  =  .1379 for peak 
vagal amplitude and F(3,9)  =  0.3474, p  =  .7179 for the 
duration of vagal bursts. In more detail, post hoc tests 
revealed that bilateral microinjections of strychnine did 
not change respiratory activity (Figure 4a), in agreement 
with our previous findings (Cinelli et al., 2014). The sub-
sequent (~5 min interval) microinjections of 1 mM (S)-
WAY 100135 at the same sites caused within 10 min only 
small decreases in respiratory frequency (from 60.7 ± 4.2 
to 51 ± 3.6 cycles/min, −16.05 ± 1.45%; p = .0064) with-
out significant changes in the amplitude and duration of 
vagal bursts (third panel in Figure 4a). Respiratory activ-
ity recovered control levels within 60 min after (S)-WAY 
100135 microinjections.
As already described in a previous report (Cinelli 
et al., 2014), bilateral microinjections of 1 mM bicuculline 
(0.5–1 pmol; n = 4) into the pTRG elicited a breathing pat-
tern characterized by irregular, prolonged vagal bursts that 
progressively developed and stabilized within 5  min in a 
double-burst pattern. Figure 4b shows that also bicuculline 
prevented (S)-WAY 100135-induced apnoea. In the anal-
ysis of (S)-WAY 100135-induced effects during GABAA 
receptor blockade, the results of a one-way repeated-mea-
sures ANOVA were as follows: F(3,9) = 42.49, p =  .0018 
for respiratory frequency, F(3,9)  =  0.3654, p  =  .6708 for 
peak vagal amplitude and F(4,12)  =  50.88, p  =  .0001 for 
vagal burst duration (see also Cinelli et al., 2014). Post hoc 
analysis showed that bilateral microinjections of bicucull-
ine did not modify the frequency (interval between duplets) 
nor modify the amplitude (mean values of each duplet) of 
vagal activity, while the duration of the first and second 
vagal burst changed from 29.0 ± 2.3 ms (control value) to 
35.6 ± 1.9 ms (23.5 ± 4.6%; p = .0176) and to 43.0 ± 2.2 ms 
(49.0  ±  5.8%; p  =  .004), respectively. In particular, post 
hoc analysis revealed that the subsequent (~5 min interval) 
microinjections of 1 mM (S)-WAY 100135 at the same sites 
did not induce apnoea, but restored within ~10 min more 
regular pattern of breathing characterized by a single-burst 
pattern similar to that observed under control conditions 
(vagal burst duration 27.8  ±  1.5  ms; p  >  .05). However, 
the respiratory frequency (third panel in Figure  4b) was 
slightly lower than control (from 59  ±  3.8 to 49.9  ±  2.7 
cycles/min, −15.15 ± 1.34%; p =  .0133). Respiratory ac-
tivity recovered control levels within 60 min after (S)-WAY 
100135 microinjections.
The concomitant blockade of both GABAA and gly-
cine receptors completely prevented the responses induced 
by (S)-WAY 100135 microinjections (Figure  4c). In more 
details, bilateral microinjections of 1  mM strychnine com-
bined with 1 mM bicuculline into the pTRG (n = 4) induced 
within 5 min a double-burst pattern of breathing similar to 
that already observed after the injection of 1 mM bicuculline 
alone. The subsequent (~5 min interval) microinjections of 
1 mM (S)-WAY 100135 did not induce any further changes 
in the ongoing respiratory activity (third panel in Figure 4c). 
F I G U R E  3  Localization of the pTRG injection site. (a) The 
pTRG region (red area) where drugs were microinjected is represented 
on a dorsal view of the mesencephalon–rhombencephalon of the 
lamprey. (b) Photomicrograph of a coronal section at the level of 
the pTRG (unbroken line in a) showing an example of the location 
of fluorescent beads (green) added to the 1 mM (S)-WAY 100135 
solution microinjected into the pTRG. The section is counterstained 
with cresyl violet. Light field and fluorescence photomicrographs 
have been superimposed. ARRN, anterior rhombencephalic reticular 
nucleus; I1, isthmic Müller cell; nVm, motor root of the trigeminal 
nerve; nVs, sensory root of the trigeminal nerve; pTRG, paratrigeminal 
respiratory group; SL, sulcus limitans of His; V, trigeminal motor 
nucleus; VII, facial motor nucleus; IX, glossopharyngeal motor 
nucleus; X, vagal motor nucleus. The ARRN and I1 were used as 
anatomical landmarks to identify the pTRG region
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Respiratory activity recovered within 60 min. These results 
were examined with the same statistical analysis (details on 
this analysis not reported). Group data showing respiratory 
responses during blockade of glycine and/or GABAA recep-
tors as well as during the subsequent local application of (S)-
WAY 100135 are illustrated in Figure 4d.
F I G U R E  4  Role of glycine and GABAA receptors in counteracting the respiratory effects induced by 5-HT1AR antagonism in the pTRG. (a) 
Bilateral microinjections of 1 mM strychnine into the pTRG did not change the ongoing pattern of breathing, but prevented the apnoeic response 
induced by 1 mM (S)-WAY 100135 injected into the same sites after an interval of ∼5 min (observation made ∼10 min after (S)-WAY 100135). 
However, the 5-HT1AR antagonist still induced small, but consistent reductions in respiratory frequency. Recovery occurred ∼60 min after (S)-
WAY 100135 injections. (b) Bilateral microinjections of 1 mM bicuculline into the pTRG caused within 5 min the appearance of a double-burst 
breathing pattern. The subsequent microinjections of 1 mM (S)-WAY 100135 performed into the pTRG did not cause apnoea. However, within 
∼10 min the double-burst breathing pattern faded out and was followed by a regular pattern of breathing characterized by a respiratory frequency 
slightly lower than control. Respiratory activity returned to control levels within ∼60 min. (c) Microinjections of 1 mM strychnine combined with 
1 mM bicuculline induced within 5 min a pattern of breathing similar to that already observed during GABAA receptor blockade. Subsequent 
bilateral microinjections of 1 mM (S)-WAY 100135 into the same sites did not change the already altered pattern of breathing (observation made 
∼10 min after (S)-WAY 100135 injections). A complete recovery was observed after ∼60 min. Traces are integrated vagal nerve activity (IVA). (d) 
Group data showing respiratory responses during blockade of glycine and/or GABAA receptors as well as during the subsequent local application 
of (S)-WAY 100135. Recovery ∼60 min after the last injections. For simplicity, only frequency (●) and amplitude (■) of vagal bursts have been 
reported. Values are means ± SEM. *p < .05, **p < .01 compared with control
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3.3 | Immunohistochemical analysis of 
5-HT1ARs and glycinergic neurons in the 
pTRG region
To corroborate these results, we assessed whether 
5-HT1ARs are located in close proximity to glycinergic 
neurons within the pTRG by double-labelling experiments 
(n = 4). As illustrated in Figure 5, glycine-immunoreactive 
neurons (red signal) were found in this region. In addition, 
photomicrographs at a higher magnification of the portion 
of the transverse section (white box in b) at the pTRG level 
display glycine-immunoreactive neuronal structures (panel 
i, red signal) and 5-HT1AR-like immunoreactive sites 
(panel ii, green signal) widely expressed in close apposi-
tion to the soma of glycine-immunoreactive cells (panel 
iii, merged image). Immunoreactivity for GABAergic 
neurons was not performed since previous studies have 
shown that GABA-immunopositive fibres, but not GABA-
immunoreactive neurons, are present within this region 
(Cinelli et al., 2014; Robertson, Auclair, Menard, Grillner, 
& Dubuc, 2007; Villar-Cervino, Barreiro-Iglesias, Anadon, 
& Rodicio, 2008).
4 |  DISCUSSION
The results show for the first time in the adult lamprey that 
5-HT exerts a tonic influence on respiration as revealed 
by the effects induced by the selective 5-HT1AR antago-
nist (S)-WAY 100135. In particular, the results imply that 
F I G U R E  5  Immunohistochemical labelling of glycinergic neurons and 5-HT1ARs in the pTRG region. (a) Schematic illustration of a dorsal 
view of the lamprey mesencephalon/rhombencephalon showing the level (unbroken line) of a coronal section (arrow) where the pTRG is located 
(red area). (b) Photomicrographs of transverse sections at the pTRG level displaying glycine immunoreactivity (red signal) and 5-HT1AR-like 
immunoreactivity (green signal). (b, panel i-iii) Photomicrographs at a higher magnification of a portion of the transverse section (white box in 
b) illustrating glycine-immunoreactive neuronal structures (panel i, red signal), 5-HT1AR binding sites (panel ii, green signal) and merged image 
(panel iii). Note the presence of 5-HT1AR-likeimmunoreactive structures located in close apposition to glycinergic neurons. Scale bars: (b), 100 μm; 
(b, panel i-iii), 50 μm; inset in panel iii, 10 μm. ARRN, anterior rhombencephalic reticular nucleus; I1, isthmic Müller cell; nVm, motor root of the 
trigeminal nerve; nVs, sensory root of the trigeminal nerve; pTRG, paratrigeminal respiratory group; V, trigeminal motor nucleus; VII, facial motor 
nucleus; IX, glossopharyngeal motor nucleus; X, vagal motor nucleus
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5-HT1ARs contribute to maintain baseline levels of res-
piratory activity by mediating a potent inhibitory control 
of both GABAergic and glycinergic mechanisms imping-
ing onto the pTRG rhythmogenic neurons. The 5-HT1AR-
mediated inhibition is conceivably acting on glycinergic 
cells and on GABAergic terminals, in agreement with 
the notion that GABAergic neurons are not present in the 
pTRG region (Cinelli et al., 2014; Robertson et al., 2007; 
Villar-Cervino et  al.,  2008). Immunohistochemical data 
are consistent with the presence of 5-HT1ARs on glycin-
ergic neurons and corroborate the present findings. We 
suggest that certain features of the 5-HT mechanisms in-
volved in the modulation of the respiratory network are 
conserved throughout evolution. Admittedly, the sample 
size for each kind of trial was low. However, the effects of 
the different treatments were very clear, while their vari-
ability was relatively low. On the other hand, as already 
mentioned, we tried to minimize the number of animals 
employed.
4.1 | Tonic control of the lamprey pTRG 
through 5-HT1ARs
In the present study, we focused on the 5-HT1AR subtype. 
A potent 5-HT-related tonic influence on respiration was 
shown by application of the 5-HT1AR antagonist (S)-WAY 
100135 (either applied to the bath or microinjected into the 
pTRG). Importantly, this tonic influence contributes to main-
tain basal respiratory activity. Changes in respiration could 
be operated by the regulation of this receptor mechanism via 
adjustments in the release of 5-HT. The results suggest that 
under in vitro conditions, this mechanism of inhibition–dis-
inhibition mediated by 5-HT1ARs is a major determinant of 
basal respiratory activity since, when it is lacking, apnoea 
occurs, and no other mechanisms, either related to 5-HTRs or 
not, are brought into action to maintain respiration. However, 
the involvement of other 5-HTR subtypes could contribute 
to explain our results. In this context, it should be mentioned 
that at the concentrations used, the 5-HT1AR antagonist (S)-
WAY 100135 may also act at the level of 5-HT1BRs and 
5-HT1DRs as a partial agonist (Davidson, Ho, Price, Jones, 
& Stamford, 1997). Interestingly, the activation of 5-HT1DRs 
appears to have a role in the control of the lamprey locomo-
tor activity. Schwartz et al.  (2005) found that the 5-HT1DR 
agonist, L694-247, prolongs the frequency of ventral root 
bursting. They also showed that this agonist presynaptically 
inhibits synaptic transmission without altering postsynaptic 
Ca2+-activated K+ currents.
Consistently with the present knowledge in mammals 
(Del Negro et al., 2018; Doi & Ramirez, 2008), other mech-
anisms are known to contribute to the respiratory con-
trol in the lamprey (see Bongianni et al., 2016 and Cinelli 
et  al.,  2017 also for further references). Some neurotrans-
mitters or neuromodulators have excitatory respiratory ef-
fects and contribute to respiratory rhythm generation, such 
as neurokinin receptor agonists, in particular the neuroki-
nin-1 receptor agonist SP (Cinelli et al., 2013, 2017; Mutolo 
et al., 2010) as well as acetylcholine (Mutolo et al., 2011) 
and glutamate (Cinelli et al., 2013). On the contrary, ATP 
is not involved in the respiratory rhythmogenesis, but it can 
contribute to respiratory modulation (Cinelli et  al.,  2017), 
while endogenous opioids exert a depressing role by acti-
vating μ-opioid receptors and, to a minor extent, δ-opioid 
receptors (Mutolo et  al.,  2007). In the lamprey pTRG, the 
endogenous tonic release of excitatory amino acids, but not 
that of GABA and glycine, has a crucial role in the respiratory 
rhythmogenesis (Bongianni et  al.,  1999, 2016; Bongianni, 
Mutolo, Nardone, & Pantaleo,  2006; Cinelli et  al.,  2013, 
2014; Martel et al., 2007; Rovainen, 1983). This occurs also 
in the mammalian pre-BötC (Bongianni, Mutolo, Cinelli, 
& Pantaleo,  2010; Del Negro et  al.,  2018; Kam, Worrell, 
Janczewski, Cui, & Feldman,  2013 also for further refer-
ences). However, in the lamprey GABAergic mechanisms 
have a tonic modulatory role on respiration while a gly-
cinergic tonic influence is lacking, as demonstrated by the 
absence of strychnine-induced respiratory effects (see also 
Cinelli et al., 2014). This latter finding is probably related 
to the tonic activation of inhibitory 5-HT1ARs on glyciner-
gic neurons (present results). Nevertheless, both GABA and 
glycine have clear potent inhibitory effects as proved by the 
counteracting effects of bicuculline and strychnine on (S)-
WAY 100135-induced depressing responses.
Most of 5-HT-immunoreactive neurons in the central 
nervous system of the adult sea lamprey have been found 
in the diencephalon, rhombencephalon and spinal cord (e.g. 
Abalo et al., 2007; Antri et al., 2006; Pierre et al., 1992). 
Noticeably, strong resemblances between lampreys and 
other vertebrates in the distribution and in the spatio-tem-
poral pattern of development of brainstem serotoniner-
gic neural populations exist (Abalo et  al.,  2007; Antri 
et al., 2006). In addition, the development of early ascend-
ing and descending serotoninergic pathways in the lamprey 
is similar to that of other vertebrates (Abalo et al., 2007). 
The comparison of the expression of 5-HT1ARs between 
sea lamprey and other vertebrates reveals a conserved pat-
tern in most brain regions (Cornide-Petronio et al., 2013). 
Serotoninergic cells have been described in close vicinity 
to or within a region encompassing the pTRG. However, 
it seems plausible to suggest that projections to the pTRG 
may originate from the dense serotoninergic population of 
neurons located in the isthmic region, which corresponds 
to the so-called superior raphe nuclei, located in the caudal 
mesencephalon and rostral rhombencephalon and present in 
all jawed vertebrates (Abalo et al., 2007; Antri et al., 2006; 
Pierre et al., 1992).
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4.2 | Disinhibition phenomena underlying 
respiratory responses due to 5-HT1AR 
antagonism within the lamprey pTRG
While no significant effects were induced by strychnine 
microinjections into the pTRG, bicuculline microinjections 
caused a characteristic double-burst pattern. The lack of ef-
fects induced by bilateral microinjections of 1 mM strych-
nine performed into the pTRG, already observed by Cinelli 
et al. (2014), could probably be related to the complete inhi-
bition of glycinergic cells via serotoninergic terminals, that is 
the absence of a glycinergic activity under basal conditions. 
On the other hand, bicuculline and gabazine microinjections 
were effective providing evidence of a tonic GABAA recep-
tor-mediated modulation of the pTRG. Bicuculline-induced 
effects were quite similar to those reported by us in a previ-
ous study (Cinelli et al., 2014) as well as those observed in 
adult rabbits (Bongianni et al., 2010; Iovino et al., 2019) and 
adult rodents (Feldman et al., 2013; Janczewski et al., 2013; 
Kam et al., 2013 also for further references). These effects 
have been attributed to an increase in the excitability of 
rhythmogenic respiratory neurons in the pTRG or in the pre-
BötC. The results obtained by applying the 5-HT1AR antago-
nist (S)-WAY 100135 following the blockade of GABAA 
and/or glycine receptors demonstrate that both GABA and 
glycine inhibitory mechanisms are involved in the (S)-WAY 
100135-induced respiratory responses. At present, the cir-
cumstances under which changes in 5-HT1AR modulation 
of baseline respiration are brought into action are obscure 
and only a matter of speculation. In agreement with previous 
findings on the distribution of glycine immunoreactivity in 
the brain of adult sea lamprey (Villar-Cervino et al., 2008), 
the present study provides evidence of the existence of 
glycinergic-immunoreactive neurons within the pTRG. The 
finding of 5-HT1AR-like immunoreactive structures in close 
apposition to the soma of glycinergic-immunoreactive neu-
rons of the pTRG corroborates our results and confirms that 
glycinergic cells are a target of 5-HT modulation within the 
pTRG.
The present results are consistent with previous find-
ings in rodents. Manzke et  al.  (2009) demonstrated in the 
perfused rodent brainstem–spinal cord preparation the exis-
tence of a respiratory network modulation through 5-HT1AR-
mediated inhibition primarily affecting glycinergic neurons. 
Interestingly, in the same report they found in the cat com-
plex 5-HT1AR-induced disinhibitory mechanisms, proba-
bly acting on glycinergic postinspiratory neurons leading 
to excitatory respiratory modulation. On the other hand, 
Corcoran et al. (2014) showed in a transgenic mouse model 
that the excitatory effects on respiratory network were due 
to the 5-HT1AR-mediated inhibition of inhibitory interneu-
rons, that could be presumed glycinergic. Recently, we have 
provided evidence in the adult rabbit (Iovino et  al.,  2019) 
that 5-HT has a prominent role in the modulation of pre-
BötC activity. On the basis of the novel findings presented in 
that study, we have suggested the existence of both pre- and 
postsynaptic serotoninergic mechanisms in the pre-BötC 
(see Fig. 8 in Iovino et al., 2019). In particular, a 5-HT1A-
mediated inhibition of pre-BötC GABAergic interneurons 
was demonstrated. The putative serotoninergic mechanisms 
subserving regulation of the respiratory network suggested 
by present results in the lamprey are schematically summa-
rized in Figure 6. As shown in this Figure, 5-HT1ARs could 
be present both presynaptically on GABAergic terminals 
and postsynaptically on glycinergic neurons. To establish 
F I G U R E  6  Schematic drawing, partially inferred from the 
present results, representing two hypothetical inhibitory mechanisms 
mediated by 5-HT1ARs within the pTRG region. Under basal 
conditions, both presynaptic 5-HT1ARs on GABAergic terminals and 
postsynaptic 5-HT1ARs on glycinergic neurons are endogenously 
activated and strongly reduce or completely suppress the release of 
the inhibitory neurotransmitters. Endogenous activation of 5-HT1ARs 
contributes to maintain the basal rhythmic respiratory activity. The 
blockade of 5-HT1ARs by the specific antagonist (S)-WAY 100135 
induces apnoea owing to disinhibition of both inhibitory GABAergic 
and glycinergic mechanisms acting on pTRG excitatory neurons. The 
blockade of both these inhibitory mechanisms, completely abolishes 
(S)-WAY 100135-induced apnoeic responses. Present results show that 
also the blockade of only a single inhibitory mechanism is sufficient 
to prevent (S)-WAY 100135-induced apnoea, thus suggesting a 
synergistic action of the two inhibitory neurotransmitters. Since small 
depressing effects on respiration occurred after (S)-WAY 100135 
microinjections during glycine receptor blockade, a concomitant 
disinhibition of the GABA release via presynaptic 5-HT1ARs on 
GABAergic terminals can be suggested. On the other hand, slight 
depressing effects on respiration were seen after (S)-WAY 100135 
microinjections during GABAA receptor blockade, thus indicating 
a possible associated disinhibition of pTRG glycinergic neurons 
operated by postsynaptic 5-HT1ARs located on their somata
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the prevailing pre- or postsynaptic location of 5-HT1ARs 
was beyond the scope of the present study. These receptors 
are endogenously activated and have suppressant effects on 
the release of the inhibitory neurotransmitters, thus contrib-
uting to maintain basal respiratory activity. Indeed, the ac-
tual circuit underlying the modulation of the pTRG by 5-HT 
and GABA could be more complex than that reported in 
Figure 6. The figure also help to explain how the (S)-WAY 
100135-mediated disinhibition of both inhibitory mecha-
nisms induces apnoea (prevented by their blockade) and, in 
addition, how the blockade of a single mechanism can still 
cause slight depressing effects on respiration probably due to 
a concomitant (S)-WAY 100135-induced disinhibition of the 
other mechanism. The absence of significant effects of the 
5-HT1AR agonists is difficult to interpret. Nevertheless, the 
circuit represented in Figure 6 could also help to provide a 
tentative explanation of this finding. The potent tonic inhib-
itory influence on both GABAergic and glycinergic mecha-
nisms exerted by endogenously released 5-HT under basal 
conditions may activate maximally pre- and postsynaptic 
5-HT1ARs, thus producing a sort of occlusion effect with the 
exogenously administered agonist. However, we must rec-
ognize that the actual explanation of our results can be more 
complex and other 5-HTR subtypes could have played a role. 
Interestingly, recent results (Ptak et  al.,  2009) have shown 
that excitatory amino acid-induced augmentation of the en-
dogenous release of 5-HT and SP from the raphe system 
in in vitro neonatal and in in situ juvenile rat preparations 
causes increases in the respiratory motor output in conse-
quence of the activation of other 5-HTR subtypes within 
the pre-BötC region. More recently, an optogenetic study by 
Depuy et  al.  (2011) performed in anaesthetized mice have 
demonstrated that more selective stimulation of raphe ob-
scurus serotoninergic neurons activates breathing and poten-
tiates the central respiratory chemoreflex. The presence and 
the role of other 5-HTR subtypes in the lamprey respiratory 
network would deserve further investigations.
The primary conclusion to be drawn from present re-
sults is that 5-HT1AR modulation affects inhibition of 
pTRG neurons through glycinergic and GABAergic 
mechanisms. This neural organization, reminiscent of the 
mammalian respiratory network, along with the strong 
similarities between lampreys and other vertebrates in the 
distribution and development of brainstem 5-HT neurons, 
strongly supports the view that some characteristics of the 
neural network subserving respiration are highly conserved 
throughout evolution (see also Grillner, 2006; Grillner & 
El Manira, 2019).
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